ArKal raises 'B' $17.5 million; NewCardio officers buy stock

September 2008
Medical Device Daily;9/17/2008, Vol. 12 Issue 199, p3
The article reports on the $17.5 million raised by ArKal Medical in a Series B financing round up which was led by Thomas McNerney & Partners. ArKal is developing a continuous glucose monitoring system which is designed to eliminate many of the inconveniences of current glucose monitoring technologies. Arvind Jina, president/chief executive officer of ArKal, says with the investment, they will fund the next stage of corporate and product milestones.


Related Articles

  • VC Model Not Broken, but Needs 'Tailor-Made' Tune Up. Morrison, Trista // BioWorld Insight;8/24/2009, Vol. 17 Issue 34, p1 

    The article discusses the biotech venture capital (VC) business model in the biotechnology industry, along with business strategies. According to Standish Fleming of Forward Ventures, a simple way to make money in the industry is through defining the customer base, knowing the sentiments of the...

  • So you want to be a venture capitalist? Brown, Jason // Nature Biotechnology;Oct2008, Vol. 26 Issue 10, p1195 

    The article discusses the role that venture capitalists play in taking scientific innovations from theoretical concepts to commercial realities. They provide financing and advice to companies with potentially successful technologies and products. The average day of an investment professional at...

  • DexCom's Seven Plus device gets CE mark.  // Biomedical Business & Technology;Nov2009, Vol. 32 Issue 11, p23 

    The article reports that DexCom of San Diego, California has received a CE mark approval for the Seven Plus continuous glucose monitoring system. The purpose of the Seven Plus, the company's third generation device, is for better management of diabetes and control of glucose levels. The plan to...

  • Venture Capital Firm Moving From Bay Area to San Diego. Allen, Mike // San Diego Business Journal;2/28/2011, Vol. 32 Issue 9, p24 

    The article reports on the plan of Thomas McNerney & Partners LLC to relocate its office from san Francisco to San Diego later in 2011 in California.

  • SG Biofuels Picks Up $17M In Series B Funding Round. Quigley, Kelly // San Diego Business Journal;3/12/2012, Vol. 33 Issue 11, p13 

    The article reports on the completion of SG Biofuels Inc. of Series B financing worth 17 million dollars, led by Thomas McNerney and Partners LLC.

  • Swiss firm gets additional funding.  // Diagnostics & Imaging Week;5/15/2008, Vol. 11 Issue 20, p8 

    The article reports that Zürich Cantonal Bank will invest in the efforts of Solianis Monitoring to develop a non-invasive glucose monitoring device. A total of 2.5 million Swiss francs has been raised. According to Solianis, the bank will participate with 500,000 Swiss francs as part of its...

  • Organovo closes underwritten public offering shares of stock.  // Medical Device Daily;8/9/2013, Vol. 17 Issue 153, p2 

    The article reports that the Organovo Holdings closed its underwritten public offering of nine million shares of its common stock based on the over-allotment option granted to its underwriters.

  • Harvard Bioscience to delay HART unit's IPO.  // Medical Device Daily;4/11/2013, Vol. 17 Issue 70, p5 

    The article offers newsbriefs including the postponement of the planned initial public offering for Harvard Apparatus Regenerative Technology, the public quotation for the stocks of Integrity Applications, and the zero coupon convertible of LabCorp.

  • CAS Medical raises $15M in new private placement.  // Medical Device Daily;6/13/2011, Vol. 15 Issue 113, p2 

    The article reports on the 15 million dollars raised by Connecticut-based CAS Medical Systems upon the completion of a private placement with Thomas, McNerney & Partners as of June 2011. The placement involved a combination of convertible preferred stock and non-voting exchangeable preferred...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics